医学
放射治疗
胰腺癌
腺癌
放射科
化疗
胰腺
癌症
肿瘤科
外科
内科学
作者
Samer Salamekh,Sujana Gottumukkala,Chunjoo Park,Mu‐Han Lin,Nina N. Sanford
标识
DOI:10.1016/j.hoc.2022.06.002
摘要
Current indications for radiotherapy in pancreatic cancer vary by surgical resectability status of the tumor. Radiation is generally not used pre-operatively for resectable tumors, but may be given adjuvantly particularly in settings of a close or positive surgical margin. For borderline resectable tumors, pre-operative radiation has been shown to improve surgical parameters including lowering nodal positivity and positive margin rates. For locally advanced unresectable tumors, radiation can improve local control, give patients an interval off of chemotherapy and provide symptomatic relief. Multidisciplinary discussion is critical for choosing the best modality and sequencing of care for patients with pancreatic cancer. Prospective trials with appropriately chosen endpoints and meticulous radiotherapy quality assurance are needed to best define populations with pancreatic cancer most likely to benefit from radiotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI